149
Views
1
CrossRef citations to date
0
Altmetric
REVIEW

Quantifying the Value of Introducing an Oral Drug Delivery Option for Edaravone: A Review of Analyses Evaluating the Economic Impact of Oral versus Intravenous Formulations

ORCID Icon, ORCID Icon, , &
Pages 499-511 | Received 12 Feb 2022, Accepted 28 Jun 2022, Published online: 27 Jul 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.